Research Topic: fungal biofilms

Enhanced biodegradation of fluorinated pharmaceutical by Aspergillus flavus and Cunninghamella elegans biofilms: kinetics and mechanisms

mycolabadmin

This research shows that two types of fungi—Aspergillus flavus and Cunninghamella elegans—can effectively break down commonly prescribed medications found in wastewater through biofilm formation on foam carriers. The fungi degrade these drugs through enzymatic action rather than absorption, removing 85-99% of the pharmaceuticals within days. This discovery offers a promising, cost-effective biological treatment for cleaning wastewater from hospitals and pharmaceutical factories, potentially protecting aquatic environments from drug pollution.

Read More »

Antifungal persistence: Clinical relevance and mechanisms

mycolabadmin

Some fungal infections don’t respond well to antifungal medications even though the fungi aren’t drug-resistant. This happens because a small percentage of fungal cells enter a dormant, low-energy state that protects them from being killed by the drugs. Understanding how these persistent cells survive and finding ways to target them could help prevent recurring fungal infections and improve treatment outcomes.

Read More »

Enhanced biodegradation of fluorinated pharmaceutical by Aspergillus flavus and Cunninghamella elegans biofilms: kinetics and mechanisms

mycolabadmin

Two types of fungi, Aspergillus flavus and Cunninghamella elegans, can effectively break down pharmaceutical pollutants commonly found in wastewater, such as antidepressants and antibiotics. When grown as biofilms on foam carriers, these fungi removed over 90% of the target pharmaceuticals very quickly. The fungi accomplish this primarily through enzymatic breakdown rather than absorption, making them promising candidates for cleaning wastewater at treatment plants.

Read More »

Characterization of Biofilm Formation by the Dermatophyte Nannizzia gypsea

mycolabadmin

This research studies how a fungus called Nannizzia gypsea forms protective biofilms on skin and hair, making infections harder to treat. Scientists grew the fungus in the lab and on real human hair, discovering it creates thick slime-like protective layers containing proteins, sugars, and DNA. The fungus also produces enzymes that break down keratin (the main protein in skin and hair) and activates drug-pumping proteins that help it resist antifungal medications. Understanding these defense mechanisms could help develop better treatments for fungal skin infections that are currently difficult to cure.

Read More »

Enhanced biodegradation of fluorinated pharmaceutical by Aspergillus flavus and Cunninghamella elegans biofilms: kinetics and mechanisms

mycolabadmin

Researchers discovered that two types of fungi, Aspergillus flavus and Cunninghamella elegans, can effectively break down common prescription drugs like fluoxetine, ciprofloxacin, and atorvastatin in wastewater. When grown as biofilms on foam carriers, these fungi removed over 90% of the pharmaceuticals in just a few days. This is an important finding because conventional wastewater treatment doesn’t effectively remove these medications, which can harm aquatic ecosystems.

Read More »

Enhanced biodegradation of fluorinated pharmaceutical by Aspergillus flavus and Cunninghamella elegans biofilms: kinetics and mechanisms

mycolabadmin

This study demonstrates that two types of fungi, Aspergillus flavus and Cunninghamella elegans, can effectively remove persistent pharmaceutical pollution from wastewater when grown as biofilms on foam carriers. The fungi achieved removal rates of 92-98% for three common medications (atorvastatin, ciprofloxacin, and fluoxetine) much faster than previously reported methods. Unlike traditional fungal treatments that depend on lignin, these fungi can work in diverse environments, making them practical for wastewater treatment plants and offering a sustainable biological solution to pharmaceutical pollution.

Read More »

Breaking down biofilms across critical priority fungal pathogens: proteomics and computational innovation for mechanistic insights and new target discovery

mycolabadmin

Fungal infections like cryptococcal meningitis and invasive aspergillosis are becoming increasingly difficult to treat because fungi form protective structures called biofilms that resist our current medications. Researchers are using advanced techniques like mass spectrometry to identify the proteins that help fungi build these biofilms, combined with artificial intelligence tools to design new drugs that could break down these protective shields. This combined approach offers hope for developing better antifungal treatments that could save millions of lives.

Read More »
Scroll to Top